Physician profile
Sotiris Stamou
NPI 1316078835
$24,780.10
in general payments reported to CMS, 2019-2025
26 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $250 · 2021: $8,375 · 2022: $1,677 · 2023: $5,006 · 2024: $8,860 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,010 · Food and Beverage: $4,184 · Travel and Lodging: $2,816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,009.50 |
| Food and Beverage | $4,184.06 |
| Travel and Lodging | $2,815.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes USA Products LLC | $9,223.20 | 2021-2024 | Na, Zipfix, Matrixrib |
| Medical Device Business Services, INC. | $7,079.51 | 2021-2024 | Matrixrib |
| Angiodynamics, INC. | $2,302.30 | 2019-2023 | Angiovac |
| Medtronic, INC. | $1,663.74 | 2021-2023 | Valiant Captivia, Corevalve Evolut R |
| Abiomed | $1,239.16 | 2022-2024 | Impella |
| Depuy Synthes Sales INC. | $688.65 | 2019-2025 | Na, Matrixrib, Zipfix |
| Boston Scientific Corporation | $659.97 | 2019-2022 | |
| Edwards Lifesciences Corporation | $438.24 | 2019-2023 | Mitris Resilia Mitral Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Zimmer Biomet Holdings, INC. | $237.89 | 2019-2023 | Sternalock Blu System |
| Cgg Medical INC | $219.03 | 2024 | |
| Atricure, INC. | $209.58 | 2021-2024 | |
| Abbott Laboratories | $179.68 | 2021-2023 | Gallant |
| Medtronic Vascular, INC. | $128.78 | 2019-2020 | |
| Lsi Solutions INC | $98.11 | 2024 | Cor-Knot |
| Philips North America LLC | $90.95 | 2023-2024 | (5091) Amb Mon & Diag Und |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $89.25 | 2023 | Teg6s Hemostasis System |
| Novartis Pharmaceuticals Corporation | $42.97 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $35.49 | 2021 | |
| Artivion, INC. | $33.57 | 2021 | |
| Ethicon US, LLC | $25.71 | 2020-2023 | Vistaseal |
| Novo Nordisk INC | $19.68 | 2024 | Wegovy |
| Merck Sharp & Dohme LLC | $19.59 | 2021 | |
| Smith+Nephew, INC. | $16.62 | 2023 | Iodosorb Ointment 40g USA, Collagenase Santyl |
| Astrazeneca Pharmaceuticals LP | $13.91 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.72 | 2023 | |
| Kls-Martin L.P. | $10.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sotiris Stamou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.